Analysts expect over 2018 rising revenue Bristol-Myers Squibb

Next Monday the American Bristol-Myers Squibb will publish its past quarter's figures. Over the current book year the total revenue will be 20,67 billion USD (consensus estimates). This is slightly more than 2016's revenue of 19,43 billion USD.

Historical revenues and results Bristol-Myers Squibb plus estimates 2018

The analysts expect for 2018 a net profit of 4,97 billion USD. For this year the consensus of the result per share is a profit of 3 USD. The price/earnings-ratio is then 20,93.

For this year the analysts expect a dividend of 1,58 USD per share. The dividend yield is then 2,52 percent. The average dividend yield of the pharmaceutical companies is a moderate 1 percent.

Based on the current number of outstanding shares Bristol-Myers Squibb 's market capitalization 104,31 billion USD.

On Wednesday the stock closed at 62,8 USD.

Historical stock prices Bristol-Myers Squibb2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.